Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50: 42 3 nM) that can lower glucose in an animal model of type 2 diabetes and demonstrates excellent developability properties.
Molecular Weight:
546.68
Purity:
98.50%
CAS Number:
[1345982-69-5]
Formula:
C28H38N2O7S
Target:
HBV|||ASBT
T3978
* VAT and and shipping costs not included. Errors and price changes excepted